AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.470
-0.140 (-3.04%)
At close: Sep 12, 2025, 4:00 PM EDT
4.530
+0.060 (1.34%)
After-hours: Sep 12, 2025, 7:58 PM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.34 billion as of September 12, 2025. Its market cap has increased by 73.69% in one year.
Market Cap
1.34B
Enterprise Value
924.79M
1-Year Change
73.69%
Ranking
Category
Stock Price
$4.47
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.34B, a decrease of -91.47%. That is a compound annual growth rate of -40.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.34B | 54.35% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
| Dec 11, 2020 | 15.66B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |